Linda Noneo turned up the heat in her van to ward off the early-morning chill that persists in northern Nevada’s high desert even in late June.
Why Alzheimer’s Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence
Why is donanemab, an investigational anti-amyloid agent for early Alzheimer’s disease, facing an approval delay? (The Guardian) Early use of erenumab (Aimovig) showed sustained efficacy
March 27, 2024